Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.6K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

373
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

2.0K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

744
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

704
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

462
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.

Thyroid : official journal of the American Thyroid Association·2010
Same author

Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder.

Alcohol (Fayetteville, N.Y.)·2010
Same author

Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.

American journal of physiology. Heart and circulatory physiology·2010
Same author

Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.

Canadian journal of physiology and pharmacology·2010
Same author

Severe extrapiramidal symptoms after nonintentional risperidone exposure in a child: case report and review of the literature.

American journal of therapeutics·2010
Same author

Pediatric cancer rates after universal folic acid flour fortification in Ontario.

Journal of clinical pharmacology·2010
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

20.1K

Is it safe to breastfeed while taking methylphenidate?

Maria Marchese, Gideon Koren, Pina Bozzo

    Canadian Family Physician Medecin De Famille Canadien
    |December 2, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Methylphenidate (MPH) is excreted in small amounts in breast milk with no reported adverse effects in infants. While MPH appears compatible with breastfeeding, long-term neurodevelopmental outcomes require further study.

    More Related Videos

    An Efficient Single—Person Technique for Milk Sampling from Laboratory Mice
    04:56

    An Efficient Single—Person Technique for Milk Sampling from Laboratory Mice

    Published on: March 28, 2025

    2.0K
    A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
    05:04

    A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect

    Published on: September 22, 2023

    1.1K

    Related Experiment Videos

    Last Updated: Mar 29, 2026

    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
    09:02

    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

    Published on: February 15, 2018

    20.1K
    An Efficient Single—Person Technique for Milk Sampling from Laboratory Mice
    04:56

    An Efficient Single—Person Technique for Milk Sampling from Laboratory Mice

    Published on: March 28, 2025

    2.0K
    A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
    05:04

    A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect

    Published on: September 22, 2023

    1.1K

    Area of Science:

    • Pharmacology
    • Neonatal Medicine
    • Neurology

    Background:

    • Narcolepsy management during lactation presents challenges for breastfeeding mothers.
    • Mothers may experience difficulties maintaining alertness, impacting infant care.
    • Concerns exist regarding medication transfer to infants via breast milk.

    Purpose of the Study:

    • To evaluate the safety and compatibility of methylphenidate (MPH) use in breastfeeding mothers with narcolepsy.
    • To determine if MPH use necessitates switching to formula feeding.

    Main Methods:

    • Literature review of studies on methylphenidate excretion in breast milk.
    • Analysis of reported adverse effects in breastfed infants exposed to MPH.
    • Assessment of current clinical recommendations regarding MPH and breastfeeding.

    Main Results:

    • Methylphenidate is present in breast milk in minimal quantities.
    • No adverse effects have been documented in breastfed infants exposed to MPH.
    • Available data suggest compatibility between MPH and breastfeeding.

    Conclusions:

    • Methylphenidate is generally considered safe for breastfeeding mothers with narcolepsy.
    • Continued breastfeeding while taking MPH is a viable option.
    • Further research is needed to ascertain long-term neurodevelopmental effects in exposed infants.